International Immunology, Vol. 14, No. 12, pp. 1459-1468,
December 2002
© 2002 Japanese Society for Immunology
Effective anti-tumor adoptive immunotherapy: utilization of exogenous IL-2-independent cytotoxic T lymphocyte clones
1 Department of Oral and Maxillofacial Surgery, and 2 Institute of Immunology, Faculty of Medicine, Kyoto University, Kyoto 606-8507, Japan 3 Department of Bioregulation, Mie University School of Medicine, Mie 514-8507, Japan
The first two authors contributed equally to this work
Correspondence to: K. Kuribayashi, Department of Bioregulation, Mie University School of Medicine, 2-174 Edobashi, Tsu 514-8507, Japan. E-mail: keiyo{at}doc.medic.mie-u.ac.jp
Transmitting editor: M. Miyasaka
To attain one of the final goals for cancer immunotherapy, cytotoxic T lymphocyte (CTL) clones were selected on the basis of exogenous IL-2 independence after limiting dilution culture from mixed lymphocyte tumor cell culture cells of FBL-3 tumor-immune spleens. About 10% of the clones could be propagated up to >5 times by weekly passages in the presence of splenic feeder and stimulating tumor cells. Two of the representative FBL-3-specific CTL clones that were able to undergo the fifth passage were expanded in large numbers for adoptive transfer by two rounds of a weekly passage with medium containing IL-2. FBL-3-specific CTL clones thus obtained showed a strong ability to eliminate the established tumors when transferred into tumor-bearing nude mice. In addition, the cells were recovered from the mouse spleen even 8 months after the transfer. The most striking differences between the CTL clones used in this experiment and those maintained conventionally in the presence of IL-2 were the abilities to produce IL-2 by themselves and the high expression level of the integrin molecule, VLA-4, that disappeared when cultured completely in the continuous presence of IL-2 in vitro during 12 weeks. In addition, concomitant with the disappearance of exogenous IL-2 independence and VLA-4 expression, the CTL clones lost their capacity to eradicate the tumor in vivo. Thus, the higher capacity of CTL clones to produce IL-2 on their own seemed to be correlated with the in vivo efficacy for tumor eradication and the long-term maintenance of their physiological profiles typical of memory T cells.
Keywords: adoptive transfer, IL-2-independent cytotoxic T lymphocyte clone, memory cytotoxic T lymphocyte, tumor eradication, VLA-4
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J. G. Casado, O. DelaRosa, G. Pawelec, E. Peralbo, E. Duran, F. Barahona, R. Solana, and R. Tarazona Correlation of effector function with phenotype and cell division after in vitro differentiation of naive MART-1-specific CD8+ T cells Int. Immunol., January 1, 2009; 21(1): 53 - 62. [Abstract] [Full Text] [PDF]
|
|